Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Fearon, K. C., Glass, D. J. & Guttridge, D. C. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell metabolism 16, 153–166, doi: 10.1016/j.cmet.2012.06.011 (2012).
2. Fearon, K. Cachexia: Treat wasting illness on multiple fronts. Nature 529, 156, doi: 10.1038/529156b (2016).
3. Dingemans, A. M., de Vos-Geelen, J., Langen, R. & Schols, A. M. Phase II drugs that are currently in development for the treatment of cachexia. Expert Opin Investig Drugs 23, 1655–1669, doi: 10.1517/13543784.2014.942729 (2014).
4. Argiles, J. M., Lopez-Soriano, F. J. & Busquets, S. Counteracting inflammation: a promising therapy in cachexia. Crit Rev Oncog 17, 253–262 (2012).
5. Baracos, V. E., DeVivo, C., Hoyle, D. H. & Goldberg, A. L. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol 268, E996–1006 (1995).
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献